COMP <GO>
TMDX vs UNH // RETURN ON INVESTED CAPITAL (ROIC)
TransMedics Group Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: TMDX 8
— UNH 5
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: TMDX
LAST: $66.67 (+1.03%) • MKT CAP: $2.31B
roic
18.10%
LAST: $400.44 (-1.60%) • MKT CAP: $359.43B
roic
12.38%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TMDX VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TMDX | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 59.90% | 88.31% | -28.41 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 18.10% | 12.38% | +5.72 | TMDX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 14.6x | 15.3x | -0.67 | TMDX | /valuation <GO> |
| Free Cash Flow Yield | 5.74% | 6.25% | -0.51 | UNH | /fcf-yield <GO> |
| Operating Margin | 17.90% | 5.32% | +12.58 | TMDX | /operating-margins <GO> |
| Net Profit Margin | 31.40% | 3.53% | +27.87 | TMDX | /net-margins <GO> |
| Revenue Growth (YoY) | 37.10% | 3.33% | +33.77 | TMDX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.29% | -2.29 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.50 | 3.09 | +0.41 | TMDX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | TMDX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 33.0 | 55.1 | -22.10 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 10.2x | 17.7x | -7.54 | TMDX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.31B | $359.43B | -$357.12B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TMDX REV | UNH REV | TMDX GROSS % | UNH GROSS % | TMDX FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $605.5M | $447.57B | 59.9% | 88.7% | $133.6M | $16.07B |
| FY 2024 | $441.5M | $400.28B | 59.4% | 88.3% | -$80.9M | $20.70B |
| FY 2023 | $241.6M | $371.62B | — | 89.6% | -$13.0M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TMDX // BETA —
UNH // BETA 0.33